Answers are grounded in this paper and cite their sources.
Ovine model shows that selective removal of cytokines and PNCs mitigates ARDS severity, suggesting a new therapeutic approach.
Simultaneous removal of cytokines and PNCs using NOA-001 significantly reduced ARDS severity by attenuating pulmonary edema and improving pulmonary gas exchange. These results suggest that NOA-001 may be a novel and promising therapeutic strategy for ARDS.
No takes yet. Share an insight, caveat, or question.
Fukuda et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: